CDK1 and colonic neoplasm: Upregulation of NF-κB and COX-2 may be involved in promoting the effect of GCs on the development of colorectal carcinoma [32] and glucocorticoid-GR-CDK1 signaling induces proliferation and invasion of colon cancer cells in mice [33].